Innoblative is Driving Innovation in the Breast Cancer SpaceInnoblative is dedicated to achieving better care for cancer patients by developing next- generation, advanced energy surgical solutions that improve the way surgeons coagulate and ablate soft tissue. Learn more about their value proposition and what's on the horizon from Alyssa Bailey, Director of Product Development.
Where did the idea and value proposition of the company start?
What led you to mHUB? How are you utilizing mHUB's resources?
How have you grown since launch and what's on the horizon for the company?
We received FDA clearance and CE mark in 2019. That was really the first huge milestone for the company. Before that it was a lot of prototyping, getting through validation testing, pre-clinical testing, all that stuff. At that point, we decided to do a quick redesign of the product for manufacturability, and then COVID hit, and that quick manufacturability update became a long haul. We are finally now gearing up to get the new and improved device validated and we've got our manufacturer set up and running. We are hoping that soon we will be ready to take the next big step either in breast clinical trials or gathering the data we would need in order to start those trials hopefully in 2022. We also recently hired a new CEO, Rick Stark, which is super exciting. He has a lot of connections and experience in the breast space which will help take us to our next big milestone. He is actively raising money to close out our SAFE round (anyone interested in investing can reach out to Rick at email@example.com).
Is there a story that comes to mind about how your company has pivoted to find success?
We're a really small team and our team has changed a lot over the years. We've gotten thrown a lot of different directions and the team has pivoted within their roles to fill the gaps and learn as we go. It’s been challenging. For example, we needed to learn how to do software and PCB testing, production, documentation, and troubleshooting, in order to advance our software to production without relying on outside vendors. Traditionally this work was done by a supplier, but in an effort to take more control of our project, we brought much of the software work in house. One of our biomedical engineers, Tommy Kurth, took it upon himself to learn how to be a software engineer. He's worked with mentors, did a lot of hard work researching it, and has become our software expert. He saved us a lot of time and money by bringing the knowledge in house. I think that's one of our greatest strengths. The whole team is really flexible and it's great for our company because now we have all these different tools in our back pocket. It's not only going to help us in our career growth, but it will also help guide future products that we design for Innoblative.